Interpace Expects to Stop Offering PancraGEN® Test Due to CMS Decision to End Reimbursement as of July 17, 2023
PremiumPress ReleasesInterpace Expects to Stop Offering PancraGEN® Test Due to CMS Decision to End Reimbursement as of July 17, 2023
1y ago
Interpace Biosciences Announces Record First Quarter 2023 Financial and Business Results
PremiumPress Releases
Interpace Biosciences Announces Record First Quarter 2023 Financial and Business Results
1y ago
Interpace Biosciences Announces Full Year and Fourth Quarter 2022 Financial and Business Results
PremiumPress Releases
Interpace Biosciences Announces Full Year and Fourth Quarter 2022 Financial and Business Results
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100